Biohaven

Surveying great inventors and businesses

Axial: https://linktr.ee/axialxyz

Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at   info@axialvc.com

Biohaven was acquired by Pfizer in 2022 for $11.6B. Founded in 2013, led by Vlad Coric & based on his lab’s work, Biohaven was started to fill the gap in neurology drug development biopharma left. Ultimately leading to the approval of Nurtec to treat migraines.

Biohaven built a pipeline around 3 main mechanisms: calcitonin gene-related peptide (CGRP) receptor antagonists, glutamate modulators, & myeloperoxidase inhibitors. The lead (i.e. Nurtec) blocks the CGRP receptor to get at the root cause of migraines & avoid vasoconstriction.

With over 1B people suffering from migraines, Pfizer acquired Nurtec. After the acquisition, Biohaven was able to keep all non-CGRP development candidates along with >$200M in cash to continue on its goal to develop best-in-class medicines in neurology.

Biohaven is a template for all inventors to follow and an inspiration for all neuroscience drug development companies. Biohaven is hiring here: https://www.biohaven.com/careers/